Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Motegrity ingredients?When does guselkumab patent expire?Prolia and osteonecrosis?Dabrafenib btd date 2023?Antiox mebendazole price?
See the DrugPatentWatch profile for Nplate
Nplate is the brand name for romiplostim, a medicine used for certain blood-clotting (platelet) problems. It is made by Amgen. [1]
Nplate is used to treat immune thrombocytopenia (ITP) in adults and children aged 1 year and older who have had an insufficient response to other treatments. [1]
Nplate is a thrombopoietin receptor agonist. It helps stimulate platelet production by activating the thrombopoietin (TPO) receptor on cells involved in making platelets. [1]
Nplate’s active ingredient is romiplostim. It is different from other thrombopoietin-receptor–related medicines that may be used for ITP, such as eltrombopag (which has a different active ingredient and formulation). [1]
No. Nplate is indicated for children aged 1 year and older as well as adults, for the specified ITP population. [1]
[1] https://www.amgen.com/newsroom/press-releases/2019/amgen-announces-efficacy-and-safety-results-for-nplate.html
Other Questions About Nplate :